These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 375088

  • 41. Nabilone and prochlorperazine: a useful combination for emesis induced by cytotoxic drugs.
    Cunningham D, Forrest GJ, Soukop M, Gilchrist NL, Calder IT, McArdle CS.
    Br Med J (Clin Res Ed); 1985 Sep 28; 291(6499):864-5. PubMed ID: 2996690
    [No Abstract] [Full Text] [Related]

  • 42. Dronabinol and prochlorperazine alone and in combination as antiemetic agents for cancer chemotherapy.
    Lane M, Smith FE, Sullivan RA, Plasse TF.
    Am J Clin Oncol; 1990 Dec 28; 13(6):480-4. PubMed ID: 2173391
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. A randomised double blind crossover study of domperidone and prochlorperazine suppositories for controlling emesis in outpatients receiving chemotherapy.
    Olver IN, Laidlaw CR, Matthews JP, Bishop JF, Hayes AM, Wolf M, Toner GC.
    Eur J Cancer; 1994 Dec 28; 30A(4):426-9. PubMed ID: 8018396
    [Abstract] [Full Text] [Related]

  • 50. Nabilone. A preliminary review of its pharmacological properties and therapeutic use.
    Ward A, Holmes B.
    Drugs; 1985 Aug 28; 30(2):127-44. PubMed ID: 2863127
    [Abstract] [Full Text] [Related]

  • 51. Double-blind randomized cross-over trial of dexamethasone and prochlorperazine as anti-emetics for cancer chemotherapy.
    Goldstein D, Levi JA, Woods RL, Russell J, Morgan J, Kerestes Z.
    Oncology; 1989 Aug 28; 46(2):105-8. PubMed ID: 2652018
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Comparison of buccal and oral prochlorperazine in the treatment of dizziness associated with nausea and/or vomiting.
    Bond CM.
    Curr Med Res Opin; 1998 Aug 28; 14(4):203-12. PubMed ID: 9891192
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. The Real-World Safety and Effectiveness of Prochlorperazine in Indian Patients with Dizziness.
    Haldipur D, Krishnamurthy N, A B.
    J Assoc Physicians India; 2020 Feb 28; 68(2):61-66. PubMed ID: 32009365
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.